Biosynthesis of leukotriene B4 in human polymorphonuclear leukocytes: Regulation by cholesterol and other lipids

Journal of Immunotoxicology

Volumn 5, Issue 4, 2008, Pages 347-352

  Zagryagskaya, A N ^a   Aleksandrov, D A ^a   Pushkareva, M A ^a   Galkina, S I ^a   Grishina, Z V ^a   Sud'Ina, G F ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

5 lipoxygenase; Cholesterol; Cholesterol sulfate; Leukotriene; Lipopolysaccharide; Polymorphonuclear leukocyte; Sulfatides

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CHOLESTEROL; CHOLESTEROL SULFATE; LEUKOTRIENE B4; LIPID; LIPOPOLYSACCHARIDE; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE;

ARTICLE; BIOSYNTHESIS; CELL FUNCTION; CHEMICAL STRUCTURE; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID STORAGE; LIPID VESICLE; NEUTROPHIL; OXYGENATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ARACHIDONATE 5-LIPOXYGENASE; CHOLESTEROL; HUMANS; LEUKOTRIENE B4; LEUKOTRIENES; LIPID METABOLISM; LIPIDS; LIPOPOLYSACCHARIDES; NEUTROPHILS; PHOSPHOLIPIDS;

PSEUDOMONAS AERUGINOSA;

EID: 65249166551     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910802482888     Document Type: Article

References (47)

1. Aleksandov, D. A., and Sud'ina, G. F. 2006. Suppression of 5-lipoxyge- nase activity by anionic cholesterol derivatives. Biomed. Khim.52:511-517.
2. Aleksandrov, D. A., Zagryagskaya, A. N., Pushkareva, M. A., Bachschmid, M., Peters-Golden, M., Werz, O., Steinhilber, D., and Sud'ina, G. F. 2006. Cholesterol and its anionic derivatives inhibit 5-lipoxygenase activa- tion in polymorphonuclear leukocytes and MonoMac6 cells. FEBS J.273:548-557.
3. Borgeat, P., Hamberg, M., and Samuelsson, B. 1976. Transformation of arachidonic acid and homo-αβ-linolenic acid by rabbit polymorpho- nuclear leukocytes. Mono-hydroxy acids from novel lipoxygenases. J. Biol. Chem. 251:7816-7820.
4. Borodin, E. A., Lanio, M. E., Khalilov, E. M., Markin, S. S., and Torkhovskaia, T. I. 1985. Extraction of cholesterol from biological membranes with pos- itively-charged micelles of phosphatidylcholine, Biull. Eksp. Biol. Med. 99:164-166.
5. Busse, W. W. 1998. Leukotrienes and in-ammation. Am. J. Respir. Crit. Care Med. 157:S210-213; Discussion S247-248.
6. Devchand, P. R., Hihi, A. K., Perroud, M., Schleuning, W. D., Spiegelman, B. M., and Wahli, W. 1999. Chemical probes that di-erentially modulate per- oxisome proliferator-activated receptor-αβ and BLTR, nuclear and cell surface receptors for leukotriene B4. J. Biol. Chem. 274:23341-23348.
7. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W. 1996. -e PPARαβ-leukotriene B4 pathway to in-ammation control. Nature 384:39-43.
8. Faurschou, M., and Borregaard, N. 2003. Neutrophil granules and secretory vesicles in in-ammation. Microbes Infect. 5:1317-1327.
9. Fialkow, L., Wang, Y., and Downey, G. P. 2007. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil func- tion. Free Rad. Biol. Med. 42:153-164.
10. Fruteau de Laclos, B., Braquet, P., and Borgeat, P. 1984. Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthe- sis in human leukocytes in vitro: E-ect of arachidonic acid concen- tration. Prostagl. Leukot. Med. 13:47-52.
11. Grishina, Z. V., Pushkareva, M. A., Pletjushkina, O. Y., Reiser, G., Peters- Golden, M., and Sud'ina, G. F. 2008. Sulfatides inhibit leukotriene synthesis in human polymorphonuclear granulocytes by a mecha- nism involving lipid rearrangement in intracellular membranes. Int. J. Biochem. Cell Biol. 40:110-124.
12. Honke, K., Zhang, Y., Cheng, X., Kotani, N., and Taniguchi, N. 2004. Biological roles of sulfoglycolipids and pathophysiology of their de-ciency. Glycoconj. J. 21:59-62.
13. Kasama, T., Miwa, Y., Isozaki, T., Odai, T., Adachi, M., and Kunkel, S. L. 2005. Neutrophil-derived cytokines: Potential therapeutic targets in in-ammation. Curr. Drug Targets In-amm. Allergy 4:273-279.
14. Kikuta, Y., Kusunose, E., Endo, K., Yamamoto, S., Sogawa, K., Fujii- Kuriyama, Y., and Kusunose, M. 1993. A novel form of cytochrome P450 family 4 in human polymorphonuclear leukocytes. cDNA clon- ing and expression of leukotriene B4 omega-hydroxylase. J. Biol. Chem. 268:9376-9380.
15. Kitson, N., Monck, M., Wong, K., -ewalt, J., and Cullis, P. 1992. -e in-uence of cholesterol 3-sulphate on phase behavior and hydro- carbon order in model membrane systems. Biochim. Biophys. Acta1111:127-133.
16. Koyama, S., Sato, E., Nomura, H., Kubo, K., Miura, M., Yamashita, T.,
17. Nagai, S., and Izumi, T. 2000. -e potential of various lipopolysac- charides to release IL-8 and G-CSF. Am. J. Physiol. 278:L658-666.
18. Kulkarni, S., Das, S., Funk, C.D., Murray, D., and Cho, W. 2002. Molecular basis of the speci-c subcellular localization of the C2-like domain of 5-lipoxygenase. J. Biol. Chem. 277:13167-13174.
19. Machado, E. R., Ueta, M. T., Lourenco, E. V., Anibal, F. F., Sorgi, C. A., Soares, E. G., Roque-Barreira, M. C., Medeiros, A. I., and Faccioli, L. H. 2005. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J. Immunol. 175: 3892-3899.
20. Nadeau, M., Fruteau de Laclos, B., Picard, S., Braquet, P., Corey, E. J., and Borgeat, P. 1984. Studies on leukotriene B4 omega-oxidation in human leukocytes. Can. J. Biochem. Cell Biol. 62:1321-1326.
21. Pande, A. H., Qin, S., and Tatulian, S. A. 2005. Membrane -uidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxy- genase. Biophys. J. 88:4084-4094.
22. Pande, A. H., Moe, D., Nemec, K. N., Qin, S., and Tatulian, S. A. 2004. Modulation of human 5-lipoxygenase activity by membrane lipids. Biochemistry 43:14653-14666.
23. Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Co-n, C. C., and Rubin, A. L. 1995. Reconstituted high density lipoprotein neutralizes Gram- negative bacterial polysaccharides in whole human blood. Infect. Immun. 63:253-258.
24. Peters-Golden, M. 1998. Cell biology of the 5-lipoxygenase pathway. Am. J. Respir. Crit. Care Med. 157:S227-31; Discussion S231-232, S247-248.
25. Peters-Golden, M., and Brock, T. G. 2001. Intracellular compartmentali- zation of leukotriene synthesis: Unexpected nuclear secrets. FEBS Lett. 487:323-326.
26. Peters-Golden, M., and Henderson, W. R., Jr. 2007. Leukotrienes. New Engl. J. Med. 357:1841-1854.
27. Peters-Golden, M., and McNish, R. W. 1993. Redistribution of 5-lipox- ygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun.196:147-153.
28. Podrez, E. A., Abu-Soud, H. M., and Hazen, S. L. 2000. Myeloperoxidase- generated oxidants and atherosclerosis. Free Rad. Biol. Med.28:1717-1725.
29. Puustinen, T., Sche-er, M. M., and Samuelsson, B. 1988. Regulation of the human leukocyte 5-lipoxygenase: Stimulation by micromolar Ca2+ levels and phosphatidylcholine vesicles. Biochim. Biophys. Acta960:261-267.
30. Radmark, O., Werz, O., Steinhilber, D., and Samuelsson, B. 2007. 5-Lipoxygenase: Regulation of expression and enzyme activity. Trends Biochem. Sci. 32:332-341.
31. Roberts, K. D., and Lieberman, S. 1970. -e biochemistry of the 3-hydroxy-αβ5-steroid sulfates. In: Chemical and Biological Aspects of Steroid Conjugation (Bernstein, S., and Solomon, S., Eds.), New York: Springer-Verlag, pp. 219-290.
32. Rouzer, C. A., and Samuelsson, B. 1987. 5-Lipoxygenase from human leu- kocytes associates with membrane in the presence of calcium. Adv. Prostagl.. -romb. Leukotr. Res. 17A:60-63.
33. Seeger, W., and Lasch, H. G. 1987. Septic lung. Rev. Infect. Dis. 9(S5): S570-579.
34. Serezani, C. H., Arono-, D. M., Jancar, S., Mancuso, P., and Peters-Golden, M. 2005. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106:1067-1075.
35. Sitrin, R. G., Emery, S. L., Sassanella, T. M., Blackwood, R. A., and Petty, H. R. 2006. Selective localization of recognition complexes for leu- kotriene B4 and formyl-Met-Leu-Phe within lipid raft microdo- mains of human polymorphonuclear neutrophils. J. Immunol.177:8177-8184.
36. Sleight, R. G., and Pagano, R. E. 1984. Transport of a -uorescent phos- phatidylcholine analog from the plasma membrane to the Golgi apparatus. J. Cell Biol. 99:742-751.
37. Soberman, R. J., Harper, T. W., Murphy, R. C., and Austen, K. F. 1985. Identi-cation and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 82:2292-2295.
38. Sud'ina, G. F., Brock, T. G., Pushkareva, M. A., Galkina, S. I., Turutin, D. V., Peters-Golden, M., and Ullrich, V. 2001. Sulphatides trigger poly- morphonuclear granulocyte spreading on collagen-coated surfaces and inhibit subsequent activation of 5-lipoxygenase. Biochem. J.359:621-629.
39. Toda, A., Yokomizo, T., and Shimizu, T. 2002. Leukotriene B4 receptors. Prostagl. Other Lipid Mediat. 68-69:575-585.
40. Tulenko, T. N., Constantinescu, D., Kikuchi, T., Cox, R.H., and Santamore, W. P. 1989. Mutual interaction of vasoconstriction and endothelial damage in stenotic arteries. Am. J. Physiol. 256:H881-889.
41. Woods, J. W., Evans, J. F., Ethier, D., Scott, S., Vickers, P. J., Hearn, L., Heibein, J. A., Charleson, S., and Singer, I. 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med.178:1935-1946.
42. Yla-Herttuala, S. 1999. Oxidized LDL and atherogenesis. Ann. N. Y. Acad. Sci. 874:134-137.
43. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. 1997. A G-protein-coupled receptor for leukotriene B4 that mediates chemo- taxis. Nature 387:620-624.
44. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., and Shimizu, T. 2000a. A second leukotriene B4 receptor, BLT2. A new therapeutic tar- get in in-ammation and immunological disorders. J. Exp. Med.192:421-432.
45. Yokomizo, T., Masuda, K., Kato, K., Toda, A., Izumi, T., and Shimizu, T.
46. 2000b. Leukotriene B4 receptor. Cloning and intracellular signaling.
47. Am. J. Respir. Crit. Care Med. 161:S51-55.